

A practical guide for neurologists and prescribers to help patients find Clobazam (Onfi) in stock. 5 actionable steps, alternatives, and workflow tips.
As a prescriber, few things are more frustrating than writing a prescription you know your patient needs, only to learn they can't fill it. For patients on Clobazam — particularly those managing Lennox-Gastaut syndrome (LGS) — a missed refill isn't just an inconvenience. It's a potential medical emergency.
Clobazam (Onfi, Sympazan) has experienced intermittent supply disruptions that continue into 2026, leaving patients and caregivers struggling to find their medication. As a provider, you're in a unique position to help bridge the gap between prescription and access.
This guide offers practical, actionable steps to help your patients find Clobazam in stock and maintain seizure control.
Understanding the current supply landscape will help you guide patients effectively:
Supply varies significantly by region and pharmacy type. Large chain pharmacies with automated inventory systems may not stock Clobazam if local demand is low, while independent and specialty pharmacies often maintain more reliable inventory.
Several factors contribute to the access problem your patients face:
For a detailed analysis, see our provider shortage briefing.
Medfinder for Providers allows you and your staff to search for Clobazam availability at pharmacies near your patient's location in real time. Instead of sending a prescription to a pharmacy that may not have stock, you can identify a pharmacy that does before the patient leaves your office.
Consider integrating a quick Medfinder check into your workflow for all Clobazam prescriptions. This single step can prevent days of frustration for your patients.
Prescribing generic Clobazam (rather than brand-name Onfi) gives pharmacies maximum flexibility to fill from whatever manufacturer has available stock. Additionally:
Identify 2–3 pharmacies in your area that reliably stock Clobazam:
Share this list with your patients and clinical staff. Having pre-identified backup pharmacies saves critical time when the primary pharmacy is out of stock.
Add a brief supply check to your appointment workflow:
Early identification of supply problems gives you time to act before the patient runs out. Document any supply concerns in the chart.
For every patient on Clobazam, consider documenting a contingency plan in the chart:
Having this plan ready means you or your covering provider can act quickly if the patient calls with a supply emergency.
When Clobazam is truly unavailable and a medication change is necessary, consider these alternatives based on the patient's clinical profile:
For patient-facing information on alternatives, share: Alternatives to Clobazam.
Share these resources with your patients:
Many patients face both availability and affordability challenges simultaneously. Resources to share:
For the full cost-saving guide to share with patients: How to Save Money on Clobazam. For the provider-focused savings guide: How to Help Patients Save Money on Clobazam.
The Clobazam supply situation demands proactive management from prescribers. By integrating availability checks into your workflow, building relationships with reliable pharmacies, documenting contingency plans, and empowering patients with the right tools and resources, you can significantly reduce the risk of treatment interruptions.
Your patients depend on consistent seizure control. A few minutes of proactive planning at each visit can prevent days of anxiety and potential seizure emergencies down the line.
Visit medfinder.com/providers to access real-time pharmacy search tools for your practice.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.